Dyne Therapeutics Cash from Financing (TTM) Trends

Dyne Therapeutics Inc (DYN)

26.02 +0.06 (+0.23%) USD | NASDAQ | May 10, 16:00

26.02 0.00 (0.00%) After-Hours: 18:53

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
March 31, 2024	433.90M
December 31, 2023	54.32M
September 30, 2023	91.38M
June 30, 2023	90.99M
March 31, 2023	66.19M
December 31, 2022	37.39M
September 30, 2022	0.276M

Date	Value
June 30, 2022	0.663M
March 31, 2022	0.589M
December 31, 2021	157.82M
September 30, 2021	146.54M
June 30, 2021	526.06M
March 31, 2021	526.03M
December 31, 2020	380.69M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

0.276M

Minimum

Sep 2022

526.06M

Maximum

Jun 2021

179.49M

Average

91.19M

Median

Cash from Financing (TTM) Benchmarks